CBALX | FBONX | CBALX / FBONX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 33 years | 4 years | - |
Gain YTD | 15.144 | 15.579 | 97% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 2000 | 250 | 800% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 9.79B | 238B | 4% |
Annual Yield % from dividends | 1.93 | 2.50 | 77% |
Returns for 1 year | 26.27 | 25.65 | 102% |
Returns for 3 years | 6.38 | 17.01 | 38% |
Returns for 5 years | 36.91 | N/A | - |
Returns for 10 years | 68.43 | N/A | - |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
FXG | 67.94 | 0.39 | +0.58% |
First Trust Cnsmr Staples AlphaDEX® ETF | |||
BMED | 26.19 | 0.13 | +0.48% |
iShares Health Innovation Active ETF | |||
AOA | 78.65 | 0.33 | +0.42% |
iShares Core Aggressive Allocation ETF | |||
AESR | 17.24 | 0.05 | +0.29% |
Anfield US Equity Sector Rotation ETF | |||
APRJ | 24.69 | 0.01 | +0.03% |
Innovator Premium Income 30 Bar ETF -Apr |